Evaluation of intravenous pamidronate & oral alendronate on bone marrow density in ?patients with major and intermedia thalassemia
Phase 2
Recruiting
- Conditions
- major and inter media thalassemia.Beta thalassaemia
- Registration Number
- IRCT2017070420258N51
- Lead Sponsor
- Vice chancellor for research, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients with major and inter media thalassemia ,age more than 10 years referred to Amir kabir hospital
Exclusion criteria: Gastrointestinal intolerance for oral medication; having an allergic drug; heart failure; liver failure; hypoparathyroidism
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Spinal bone density and femoral neck. Timepoint: End of one years. Method of measurement: X-ray photography.;Improve the status of clinical symptoms. Timepoint: End of one years. Method of measurement: clinical observation.
- Secondary Outcome Measures
Name Time Method